SignalXSignalX

SXT SENSIENT TECHNOLOGIES CORP

Q3 2025 10-Q
Filed: Nov 4, 2025Period ending Sep 30, 2025
Health Care
Industrial Organic ChemicalsSEC EDGAR
SENSIENT TECHNOLOGIES CORP Overview

SENSIENT TECHNOLOGIES CORP (SXT) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 4, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

  • • Newly added risk: Portfolio Optimization Plan costs increased by $3.3M in Q3 2025, impacting gross margin and operating expenses due to plant closures and restructuring
  • • Most materially updated risk: Tariff risk, with new U.S. tariffs enacted raising costs on raw materials and finished goods, potentially materially impacting profitability if not offset by pricing
+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$412M

Net Income

$37M

Operating Margin

14.0%

Net Margin

9.0%

ROE

3.1%

Total Assets

$2.2B

Source: XBRL data from SENSIENT TECHNOLOGIES CORP Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on SENSIENT TECHNOLOGIES CORP

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.